Bladder Cancer Clinical Trial
First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC
Summary
The purpose of this study is to compare the safety and efficacy of EN3348 (MCC) versus BCG as first line treatment in patients with non-muscle invasive bladder cancer that are at high risk for recurrence or progression.
Eligibility Criteria
Inclusion Criteria:
histologically confirmed urothelial carcinoma of the bladder (high grade Ta or T1 papillary lesions, CIS)
histologically confirmed diagnosis within 42 days of study treatment
life expectancy of greater than 5 years
ECOG performance status of 2 or less
absence of urothelial carcinoma involving the upper urinary tract or prostatic urethra within 12 months from start of study treatment
Exclusion Criteria:
current or previous history of muscle invasive bladder tumors (>T2)
current or previous history of lymph node and/or distant metastases from bladder cancer
current evidence of squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the bladder
current systemic cancer therapy
previous immunotherapy for bladder cancer
previous intravesical chemotherapy treatment
contraindication to use BCG of known tolerance to BCG
history of malignancy of any organ system within the past 5 years (with the exception of basal cell or squamous cell carcinoma, stage T1 prostate cancer, carcinoma in situ of the cervix, colon polyps)
patients who cannot tolerate intravesical administration or intravesical surgical manipulation (cystoscopy or biopsy)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Laguna Hills California, , United States
Los Angeles California, , United States
San Diego California, , United States
Englewood Colorado, , United States
Daytona Beach Florida, , United States
Overland Park Kansas, , United States
Shreveport Louisiana, , United States
Garden City New York, , United States
New York New York, , United States
Pittsburgh Pennsylvania, , United States
Myrtle Beach South Carolina, , United States
McAllen Texas, , United States
Salt Lake City Utah, , United States
Norfolk Virginia, , United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.